CLINICAL_TRIALS
trial_result
· 2022-09-28
Clinical Trial Update: Vitamin D Supplementation in Multiple Sclerosis [Phase 3]
Summary
Phase 3 clinical trial evaluating vitamin D supplementation in relapsing-remitting multiple sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2022-09-28